Accutane Risk Management Program Will Be Subject Of FDA Committee
Executive Summary
FDA plans to convene an advisory committee this winter to assess the risk management program designed to prevent birth defects associated with Roche's acne therapy Accutane (isotretinoin)
You may also be interested in...
Accutane Legislation Planned; Rep. Stupak Wants Mandatory Registries
Rep. Bart Stupak (D-Mich.) is drafting legislation to mandate patient and prescriber registries for the acne drug Accutane
Accutane Legislation Planned; Rep. Stupak Wants Mandatory Registries
Rep. Bart Stupak (D-Mich.) is drafting legislation to mandate patient and prescriber registries for the acne drug Accutane
Roche, Generic Firms Offer SMART-er Accutane Risk Management Plan
Roche and generic manufacturers' "consensus proposal" for additional Accutane (isotretinoin) risk management strategies will include mandatory patient and physician registries